Moderna Inc. stock - "The end of a pandemic Stock"
Moderna, a drugmaker with just a single product to its name
, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.
Shares of Moderna Inc. MRNA, +5.56% slid 9.72% to $111.40 Monday, on what proved to be an all-around favourable
trading session for the stock market, with the NASDAQ Composite Index
#moderna #mrna #Mrna
, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.
Shares of Moderna Inc. MRNA, +5.56% slid 9.72% to $111.40 Monday, on what proved to be an all-around favourable
trading session for the stock market, with the NASDAQ Composite Index
#moderna #mrna #Mrna
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.